It might be due to the phenomenon of metabolic reprogramming in cancer cells involving glycolysis and the Krebs cycle and/or the mechanism of drug efflux through P-glycoprotein/MDR1 (Pgp) transporters or increased reactive oxygen species (ROS) and free radicals through the redox dox cycle (2, 3). The gene discussed is ABCB1; the disease is cancer.